Enzymes
Studying this course? Keep your progress in one place.
Key facts
- Enzymes are proteins that act as biological catalysts, lowering the activation energy by an alternative route.
- The substrate fits the active site and forms an enzyme–substrate complex.
- Active sites are stereospecific: they fit only one enantiomer.
- A drug can act as an inhibitor by binding in the active site so the substrate cannot.
- Computer modelling screens many molecules before any are made, saving time and cost.
Enzymes as protein catalysts
An enzyme is a protein that speeds up a reaction by providing an alternative route with a lower activation energy.
Enzymes are proteins that act as biological catalysts.
Like all catalysts they speed up a reaction by providing an alternative route with a lower activation energy, and are not used up.
Their shape comes from the protein's tertiary structure, held by hydrogen bonds and S–S bonds.
- Enzymealternative route, lower activation energy
How does an enzyme speed up a reaction?
The active site
The substrate has a shape complementary to the active site, binds to it and is converted to products.
The active site is a region of the enzyme with a specific three-dimensional shape and arrangement of groups.
The substrate has a complementary shape, binds to the active site by intermolecular forces and forms an enzyme–substrate complex.
The substrate is converted into products, which leave the active site. The enzyme is then free to bind another substrate molecule.
- 1
Substrate binds
to the active site
- 2
Enzyme–substrate complex forms
by intermolecular forces
- 3
Substrate becomes products
the reaction takes place
- 4
Products leave
the enzyme is free again
Then back to step 1
What is the enzyme–substrate complex?
Stereospecific active sites
The active site has a specific 3D shape that fits only one enantiomer of a chiral molecule.
Many biological molecules are chiral and exist as two enantiomers, which are non-superimposable mirror images.
The active site is stereospecific: it has a specific 3D shape that fits only one enantiomer.
The other enantiomer has the same formula but its groups are arranged differently in space, so it cannot bind in the same way. This applies to substrates and to drugs.
- 1
One enantiomer
Its groups match the active site, so it binds
- 2
Product forms
The reaction is catalysed
- 3
Mirror-image enantiomer
Same formula but groups arranged differently in space
- 4
Cannot bind
It does not fit the active site
- Active site: specific 3D shapefits only one enantiomer
Why can an enzyme usually bind only one enantiomer?
Enzyme inhibitors as drugs
A drug with a shape complementary to the active site binds there, so the substrate cannot bind and the reaction slows or stops.
An enzyme inhibitor is a molecule that binds to the active site and blocks it.
A drug whose shape is complementary to the active site (often similar to the substrate) fits into it, so the substrate cannot bind and the reaction slows or stops.
This is the principle behind many drugs, such as antibiotics that block enzymes bacteria need.
- 1
Drug has a complementary shape
often similar to the substrate
- 2
Drug binds in the active site
blocking it
- 3
Substrate cannot bind
the reaction slows or stops
How does an inhibitor drug stop an enzyme working?
Computers in drug design
Modelling shows the shape of the active site and screens many candidate molecules before any are made.
Computer modelling shows the 3D shape of the active site and predicts how well candidate molecules fit and bind.
Many molecules can be screened before any are made, saving time and cost and reducing laboratory work.
Because the active site is stereospecific, a drug is often made as a single enantiomer: the other is wasted, may need a larger dose, and can cause side effects.
- 1
Model the active site
Its 3D shape is built on screen
- 2
Screen candidates
Many molecules are tested for fit before any are made
- 3
Choose the best fit
Prefer a single enantiomer
- 4
Make and test
Only the best candidates enter the laboratory
- Computer modellingscreen many molecules before any are made
Give two advantages of computer modelling in drug design.
Try an exam question
Explain how a drug can act as an enzyme inhibitor, and why the drug is often made as a single enantiomer.
[4 marks]
- [1]The drug has a shape complementary to the active site.
- [1]It binds to the active site, so the substrate cannot bind.
- [1]The active site is stereospecific, so only one enantiomer fits.
- [1]The other enantiomer is wasted (or may need a larger dose or cause side effects).
That's the notes covered.
Carry on to the next subtopic.
Try a question
Which statement about enzymes is correct?
1 mark, marked against the mark scheme
Which statement about enzymes is correct?
1 mark, marked against the mark scheme